Correction to: siRNA modification and delivery for drug development: (Trends in Molecular Medicine, 28:10 p:892–893, 2022) (Trends in Molecular Medicine (2022) 28(10) (892–893), (S1471491422002040), (10.1016/j.molmed.2022.08.003))

Mengjie Zhang, Yuanyu Huang*

*此作品的通讯作者

科研成果: 期刊稿件 › 评论/辩论

Article has an altmetric score of 1

摘要

In the original version of Figure 2, we showed some examples of chemical modification designs. In order to provide more accurate information, we changed several 2′-O-methyl (2′-OMe) modification sites with 2′-deoxy-2′-fluoro (2′-F) in the second example in Figure 2. We also slightly modified the chemical structures of inverted abasic deoxyribonucleotide (invAb). We apologize for any confusion this caused.[Formula

源语言英语
期刊Trends in Molecular Medicine
DOI
出版状态已接受/待刊 - 2022

访问文件

其它文件与链接

指纹

探究 'Correction to: siRNA modification and delivery for drug development: (Trends in Molecular Medicine, 28:10 p:892–893, 2022) (Trends in Molecular Medicine (2022) 28(10) (892–893), (S1471491422002040), (10.1016/j.molmed.2022.08.003))' 的科研主题。它们共同构成独一无二的指纹。
查看全指纹

引用此

Zhang, M., & Huang, Y. (已接受/印刷中). Correction to: siRNA modification and delivery for drug development: (Trends in Molecular Medicine, 28:10 p:892–893, 2022) (Trends in Molecular Medicine (2022) 28(10) (892–893), (S1471491422002040), (10.1016/j.molmed.2022.08.003)). Trends in Molecular Medicine. https://doi.org/10.1016/j.molmed.2022.09.003